CompletedPhase 3ACTRN12611000717954
Efficacy of clorpactin('registered trademark (R)) in bladder pain syndrome/interstitial cystitis: a randomised placebo-controlled trial
Efficacy of clorpactin(R) in bladder pain syndrome/interstitial cystitis: a randomised placebo-controlled trial
Sponsor
Mercy Hospital for Women
Enrollment
54 participants
Start Date
Mar 1, 2012
Study Type
Interventional
Conditions
Summary
A randomised trial assessing the efficacy of Clorpactin instillation in women with Bladder pain syndrome/Interstitial cystitis
Eligibility
Sex: FemalesMin Age: 18 YearssMax Age: 70 Yearss
Inclusion Criteria2
- Females 18-70 years old
- Diagnosed with bladder pain syndrome/interstitial cystitis
Exclusion Criteria5
- Allergy to clorpactin(R) or it’s constituent parts
- History of renal impairment or vesico-ureteric reflux
- Contraindication to general anaesthetic
- Unable to sign consent
- Unable to attend followup or complete questionnaires
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Clorpactin (sodium oxychlorosene) 0.4% solution (2gm in 500ml sterile water) given as a single intravesical instillation under general anaesthetic
Clorpactin (sodium oxychlorosene) 0.4% solution (2gm in 500ml sterile water) given as a single intravesical instillation under general anaesthetic
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12611000717954